google-site-verification: googlec7193c3de77668c9.html

Developing a human hepatocyte model with enhanced drug-metabolizing enzyme activity

[
A research team led by Associate Professor Shinpei Yamaguchi and the late Professor Masako Tada of the Faculty of Science, together with Professor Yojiro Anzai and Lecturer Yohei Iizaka of the Faculty of Pharmaceutical Sciences at Toho University, have developed a new HepaRG cell line with markedly enhanced activity of CYP2D6, a major drug-metabolizing enzyme. This engineered human hepatocyte model enables more human-relevant evaluation of drug-induced hepatotoxicity mediated by CYP2D6. The study was published in the journal PLOS ONE on December 29, 2025.


Source link

Advertisements
Views: 3

See also  Scientists highlight negative impacts of sleep disruption on early brain development

Check Also

New study sheds light on how Epstein-Barr virus may contribute to multiple sclerosis

[ Multiple sclerosis (MS) is a chronic autoimmune disorder that attacks the central nervous system. …

First death reported in Legionnaires' disease outbreak in New York City

[ A Legionnaires’ disease outbreak that has sickened dozens of people in New York City …

Machine learning improves identification of asthma risk in children

[ Credit: Pixabay/CC0 Public Domain A machine learning tool that analyzes information already captured in …

Leave a Reply

Available for Amazon Prime